The ultimate aim of this study is to produce a composite of bimetallic platinum-cobalt nanoparticles and reduced graphene oxide (Pt-Co@rGO) based biosensor for the detection of ascorbic acid (AA), dopamine (DA) and uric acid (UA). Those are biologically important molecules with the key functions for the human body. Pt-Co@rGO was synthesized using a microwave-assisted technique and utilized for the production of a highly sensitive and stable electrochemical biosensor. Detailed spectral XPS and Raman analysis, XRD, and TEM/HR-TEM characterization were also studied. Due to the superior activity and excellent conductivity of rGO, well-separated oxidation peaks of these biomolecules is proven by DPV (differential pulse voltammetry) and CV (cyclic voltammetry) measurements. The prepared Pt-Co@rGO-based biosensor showed high electrochemical activity, a broad linear response, high sensitivity, and acceptable limit of detection values for individual and simultaneous determination of AA, DA, and UA, under optimized conditions. The linear range of Pt-Co@rGO was found to be 170-200; 35-1500 and 5-800 µM for AA, DA, and UA, respectively. Moreover, the detection limit of the prepared composite was calculated as 0.345; 0.051; 0.172 µM for AA, DA, and UA, respectively. In the field of electrochemical biosensors, Pt-Co@rGO based sensor is highly promising due to its superior sensitivity and good selectivity properties.
No takes yet. Share an insight, caveat, or question.
Demirkan et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: